4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000016
COO and SVP, R&D acquired 38,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Johnston Lloyd P. · COO and SVP, R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-04 | Grant or award : show line 1 in the form | +38,000 | 57,734 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-01-04 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +230,000 | $2.99 | 2031-01-03 | 230,000 | 230,000 | D |
Loading xslF345X03/wf-form4_160996977743505.xml…